Search research articles
Contact Us
Filters
Showing results (111-120 of 813) with videos related to
Page
of 82
Sort By:
American Heart Journal
|
June 1, 1990
Superiority of warfarin over aspirin long term after thrombolytic therapy for acute myocardial infarction
T L Schreiber, D H Miller, D Silvasi, et al.
Multiple Sclerosis and Related Disorders
|
April 17, 2015
A pilot MRI study of white and grey matter involvement by multiple sclerosis spinal cord lesions
H Kearney, K A Miszkiel, M C Yiannakas, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
May 9, 2002
Role of magnetic resonance imaging in the diagnosis and monitoring of multiple sclerosis: consensus report of the White Matter Study Group
M Filippi, V Dousset, H F McFarland, et al.
Journal of Neurology
|
October 20, 1999
Long-term recovery and fellow eye deterioration after optic neuritis, determined by serial visual evoked potentials
A Brusa, S J Jones, R Kapoor, et al.
Magnetic Resonance Imaging
|
July 6, 2004
Cervical spinal cord MTR histogram analysis in multiple sclerosis using a 3D acquisition and a B-spline active surface segmentation technique
S J Hickman, A Hadjiprocopis, O Coulon, et al.
Magnetic Resonance Imaging
|
September 28, 1999
MRI enhancing lesion frequency from patients with MS enrolled in the placebo arms of clinical trials or in natural history studies
M P Sormani, P D Molyneux, F Barkhof, et al.
Magnetic Resonance Imaging
|
February 20, 2003
Precise estimate of fundamental in-vivo MT parameters in human brain in clinically feasible times
A Ramani, C Dalton, D H Miller, et al.
Magnetic Resonance in Medicine
|
September 1, 1989
Precise relaxation time measurements of normal-appearing white matter in inflammatory central nervous system disease
D H Miller, G Johnson, P S Tofts, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 22, 1998
Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups
N Tubridy, H J Ader, F Barkhof, et al.
European Neurology
|
November 30, 2000
Immunological time-course of gadolinium-enhancing MRI lesions in patients with multiple sclerosis
G Giovannoni, N C Silver, C D Good, et al.
Page
of 82
Search research articles
Search
Showing results (111-120 of 813) with videos related to
Sort By:
Page
of 82
American Heart Journal
|
June 1, 1990
Superiority of warfarin over aspirin long term after thrombolytic therapy for acute myocardial infarction
T L Schreiber, D H Miller, D Silvasi, et al.
Multiple Sclerosis and Related Disorders
|
April 17, 2015
A pilot MRI study of white and grey matter involvement by multiple sclerosis spinal cord lesions
H Kearney, K A Miszkiel, M C Yiannakas, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
May 9, 2002
Role of magnetic resonance imaging in the diagnosis and monitoring of multiple sclerosis: consensus report of the White Matter Study Group
M Filippi, V Dousset, H F McFarland, et al.
Journal of Neurology
|
October 20, 1999
Long-term recovery and fellow eye deterioration after optic neuritis, determined by serial visual evoked potentials
A Brusa, S J Jones, R Kapoor, et al.
Magnetic Resonance Imaging
|
July 6, 2004
Cervical spinal cord MTR histogram analysis in multiple sclerosis using a 3D acquisition and a B-spline active surface segmentation technique
S J Hickman, A Hadjiprocopis, O Coulon, et al.
Magnetic Resonance Imaging
|
September 28, 1999
MRI enhancing lesion frequency from patients with MS enrolled in the placebo arms of clinical trials or in natural history studies
M P Sormani, P D Molyneux, F Barkhof, et al.
Magnetic Resonance Imaging
|
February 20, 2003
Precise estimate of fundamental in-vivo MT parameters in human brain in clinically feasible times
A Ramani, C Dalton, D H Miller, et al.
Magnetic Resonance in Medicine
|
September 1, 1989
Precise relaxation time measurements of normal-appearing white matter in inflammatory central nervous system disease
D H Miller, G Johnson, P S Tofts, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 22, 1998
Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups
N Tubridy, H J Ader, F Barkhof, et al.
European Neurology
|
November 30, 2000
Immunological time-course of gadolinium-enhancing MRI lesions in patients with multiple sclerosis
G Giovannoni, N C Silver, C D Good, et al.
Page
of 82